Edition:
United States

Luminex Corp (LMNX.OQ)

LMNX.OQ on NASDAQ Stock Exchange Global Select Market

20.41USD
26 May 2017
Change (% chg)

$-0.01 (-0.05%)
Prev Close
$20.42
Open
$20.37
Day's High
$20.51
Day's Low
$20.30
Volume
52,891
Avg. Vol
88,157
52-wk High
$23.75
52-wk Low
$17.65

Latest Key Developments (Source: Significant Developments)

Luminex Corp receives FDA clearance for Aries Bordetella Assay
Wednesday, 3 May 2017 08:00am EDT 

May 3 (Reuters) - Luminex Corp : :Luminex Corporation receives FDA clearance for Aries Bordetella Assay.Luminex Corp- also achieved ce-ivd marking for Aries Bordetella Assay, is preparing to submit its clostridium difficile assay to FDA later this month.Luminex Corp- also is in process of completing a group a streptococcus clinical trial as it seeks to further expand its Aries menu.  Full Article

Luminex Corp Q1 gaap earnings per share $0.21
Monday, 1 May 2017 04:05pm EDT 

May 1 (Reuters) - Luminex Corp ::Luminex Corp says Q1 total Verigene related revenue of $10.5 million; growth of 59% over its Q1 2016.Luminex Corporation reports record first quarter 2017 financial results; raises 2017 financial guidance.Q1 GAAP earnings per share $0.21.Sees q2 2017 revenue $74 million to $76 million.Q1 revenue $77.8 million versus I/B/E/S view $74.2 million.Q1 non-GAAP earnings per share $0.28.Sees fy 2017 revenue $300 million to $310 million.Q1 earnings per share view $0.07 -- Thomson Reuters I/B/E/S.Q2 earnings per share view $0.07, revenue view $75.0 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $0.32, revenue view $301.3 million -- Thomson Reuters I/B/E/S.  Full Article

Luminex Corp announces cash dividend of $0.06
Tuesday, 21 Feb 2017 04:05pm EST 

Luminex Corp : Luminex corporation announces initiation of cash dividend .Luminex corp - board of directors intends for company to pay a regular quarterly cash dividend of $0.06 to holders of its common stock,.  Full Article

Luminex corporation reports Q4 GAAP loss per share $0.08
Monday, 6 Feb 2017 04:05pm EST 

Luminex Corp : Luminex Corporation reports fourth quarter and full year 2016 results . Q4 GAAP loss per share $0.08 . Sees Q1 2017 revenue $73 million to $75 million . Q4 earnings per share view $0.09 -- Thomson Reuters I/B/E/S . Sees FY 2017 revenue $295 million to $305 million . Q4 non-GAAP earnings per share $0.11 . Luminex Corp- Luminex reiterates its 2017 annual revenue guidance range to between $295 million and $305 million . Luminex Corp- anticipates Q1 2017 revenue to be between $73 million and $75 million . FY2017 earnings per share view $0.51, revenue view $299.6 million -- Thomson Reuters I/B/E/S .Q1 revenue view $74.2 million -- Thomson Reuters I/B/E/S.  Full Article

Luminex announces preliminary revenue for Q4 2016
Monday, 9 Jan 2017 08:30am EST 

Luminex Corp : Luminex announces preliminary revenue for fourth quarter 2016 and issues 2017 revenue guidance; to present at 35th annual J.P. Morgan Healthcare Conference . Sees Q4 2016 revenue about $72 million . Sees FY 2017 revenue $295 million to $305 million . Q4 revenue rose 32 percent to $9.0 million . Q4 revenue view $70.3 million -- Thomson Reuters I/B/E/S . Conducted reorganization in December of 2016 to both facilitate integration of nanosphere and to better focus on core business . Restructuring included headcount reduction of over 50 employees, reallocation of responsibilities within research and development organization .To recognize charge of about $2.5 million in Q4 of 2016 in conjunction with reorganization, expects total annualized savings of about $9 million.  Full Article

Luminex Corporation posts Q3 adj. earnings per share $0.21
Monday, 31 Oct 2016 04:05pm EDT 

Luminex Corp : Luminex Corp- revised full-year revenue guidance factors in a contribution from Nanosphere of between $7.5 million and $8.5 million in Q4 of 2016 . Luminex Corporation reports third quarter 2016 results; raises full year guidance . Q3 GAAP earnings per share $0.06 . Q3 revenue $71.2 million versus I/B/E/S view $68.6 million . Q3 earnings per share view $0.10 -- Thomson Reuters I/B/E/S . Q3 non-GAAP earnings per share $0.21 . Sees Q4 2016 revenue $7.5 million to $8.5 million .Sees FY 2016 revenue $267 million to $270 million.  Full Article

Luminex receives FDA emergency use authorization
Monday, 8 Aug 2016 08:30am EDT 

Luminex Corp :Luminex Corporation receives FDA emergency use authorization for Zika virus molecular detection assay.  Full Article

Luminex Corp posts Q2 GAAP earnings per share of $0.13
Thursday, 28 Jul 2016 04:05pm EDT 

Luminex Corp : Luminex corporation reports second quarter 2016 results . Q2 gaap earnings per share $0.13 . Sees q3 2016 revenue $67 million to $70 million . Q2 revenue $64.2 million versus i/b/e/s view $61 million . Q2 earnings per share view $0.15 -- Thomson Reuters I/B/E/S . Q2 non-gaap earnings per share $0.33 .Sees fy 2016 revenue $261 million to $269 million.  Full Article

Luminex says, upon termination of merger agreement, Nanosphere would have to pay termination fee of $2.25 mln
Monday, 23 May 2016 06:52am EDT 

Luminex Corp : Upon termination of merger agreement, under specified circumstances, Nanosphere would have been required to pay co termination fee of $2.25 million .Under amendment to merger agreement, increased break-up fee to $3 million - sec filing.  Full Article

Nanosphere to pay Luminex fee of $2.25 mln upon termination of merger - SEC filing
Monday, 16 May 2016 06:31am EDT 

Nanosphere Inc : Upon termination of merger agreement, company will be required to pay luminex a termination fee of $2.25 million - sec filing . Merger agreement provides waiver of non-compete covenants in employment agreement of michael mcgarrity, company's president and ceo Further company coverage: [NSPH.O] (Bengaluru Newsroom: +1-646-223-8780).  Full Article

More From Around the Web

BRIEF-Luminex Corp Q1 gaap earnings per share $0.21

* Luminex Corp says Q1 total Verigene related revenue of $10.5 million; growth of 59% over its Q1 2016